Literature DB >> 7815463

T-type calcium current in latent pacemaker cells isolated from cat right atrium.

Z Zhou1, S L Lipsius.   

Abstract

Whole-cell voltage clamp techniques were used to study Ca2+ currents in latent pacemaker cells isolated from cat right atrium. T-type (ICa,T) and L-type (ICa.L) Ca2+ currents were distinguished by their voltage dependence of activation, and sensitivity to channel blocking agents. In 2.7 mM [Ca]o, ICa,T activation exhibited a voltage threshold of about -50mV and maximum amplitude at -10mV, whereas ICa,L threshold was about -30mV and maximum amplitude was at +10mV. The half-maximal activation voltages of ICa,T was -31.4 +/- 0.2mV and ICa,L was -6.2 +/- 2.0mV. Overlap of the steady-state activation-inactivation curves for ICa,T showed a "window" current at voltages compatible with the late phase of diastolic depolarization. Maximum ICa,T and ICa,L current densities were 3.3 +/- 0.4pA/pF and 12.5 +/- 1.3pA/pF, respectively. ICa,T current density in working atrial muscle cells was 0.73 +/- 0.31pA/pF. Both ICa,L and ICa,T were blocked by 2mM cobalt. ICa,L but not ICa,T was blocked by 1 microM nifedipine. Nickel (Ni2+; 40 microM) inhibited ICa,T primarily at more negative voltages. In addition, Ni2+ decreased the late phase of diastolic depolarization and significantly increased pacemaker cycle length. These results indicate that latent atrial pacemaker cells exhibit ICa,T that is significantly larger in amplitude than in working atrial muscle cells. ICa,T may contribute current during the late phase of diastolic depolarization. Because latent pacemakers exhibit a more negative maximum diastolic potential, ICa,T may contribute more to latent than to primary pacemaker activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7815463     DOI: 10.1006/jmcc.1994.1139

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  21 in total

1.  pH modification of human T-type calcium channel gating.

Authors:  B P Delisle; J Satin
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

2.  Intracellular Ca2+ release contributes to automaticity in cat atrial pacemaker cells.

Authors:  J Hüser; L A Blatter; S L Lipsius
Journal:  J Physiol       Date:  2000-04-15       Impact factor: 5.182

Review 3.  Low-voltage-activated ("T-Type") calcium channels in review.

Authors:  Anne Marie R Yunker; Maureen W McEnery
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

4.  T-type Ca2+ current as a trigger for Ca2+ release from the sarcoplasmic reticulum in guinea-pig ventricular myocytes.

Authors:  K R Sipido; E Carmeliet; F Van de Werf
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

5.  Both T- and L-type Ca2+ channels can contribute to excitation-contraction coupling in cardiac Purkinje cells.

Authors:  Z Zhou; C T January
Journal:  Biophys J       Date:  1998-04       Impact factor: 4.033

6.  Distinct roles of L- and T-type voltage-dependent Ca2+ channels in regulation of lymphatic vessel contractile activity.

Authors:  Stewart Lee; Simon Roizes; Pierre-Yves von der Weid
Journal:  J Physiol       Date:  2014-10-17       Impact factor: 5.182

Review 7.  Ion Channels in the Heart.

Authors:  Daniel C Bartos; Eleonora Grandi; Crystal M Ripplinger
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

8.  Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H.

Authors:  J H Lee; J C Gomora; L L Cribbs; E Perez-Reyes
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

9.  A model of cellular cardiac-neural coupling that captures the sympathetic control of sinoatrial node excitability in normotensive and hypertensive rats.

Authors:  T Tao; David J Paterson; Nicolas P Smith
Journal:  Biophys J       Date:  2011-08-03       Impact factor: 4.033

Review 10.  Clinical pharmacokinetics of mibefradil.

Authors:  H A Welker; H Wiltshire; R Bullingham
Journal:  Clin Pharmacokinet       Date:  1998-12       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.